Literature DB >> 27297480

Multicenter Comparison of the Etest and EUCAST Methods for Antifungal Susceptibility Testing of Candida Isolates to Micafungin.

M-E Bougnoux1, E Dannaoui2, I Accoceberry3, A Angoulvant4, E Bailly5, F Botterel6, S Chevrier7, T Chouaki8, M Cornet9, F Dalle10, A Datry11, A Dupuis1, A Fekkar12, J P Gangneux7, J Guitard13, C Hennequin13, Y Le Govic14, P Le Pape15, D Maubon9, S Ranque16, M Sautour11, B Sendid17, J Chandenier18.   

Abstract

In vitro susceptibility of 933 Candida isolates, from 16 French hospitals, to micafungin was determined using the Etest in each center. All isolates were then sent to a single center for determination of MICs by the EUCAST reference method. Overall essential agreement between the two tests was 98.5% at ±2 log2 dilutions and 90.2% at ±1 log2 dilutions. Categorical agreement was 98.2%. The Etest is a valuable alternative to EUCAST for the routine determination of micafungin MICs in medical mycology laboratories.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27297480      PMCID： PMC4958160          DOI： 10.1128/AAC.00630-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  21 in total

1.  Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST).

Authors:  M Cuenca-Estrella; M C Arendrup; E Chryssanthou; E Dannaoui; C Lass-Florl; P Sandven; A Velegraki; J L Rodriguez-Tudela
Journal:  Clin Microbiol Infect       Date:  2007-08-13       Impact factor: 8.067

2.  Comparison of micafungin MICs as determined by the Clinical and Laboratory Standards Institute broth microdilution method (M27-A3 document) and Etest for Candida spp. isolates.

Authors:  Ana Espinel-Ingroff; Emilia Cantón; Teresa Pelaez; Javier Pemán
Journal:  Diagn Microbiol Infect Dis       Date:  2011-05       Impact factor: 2.803

3.  ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.

Authors:  O A Cornely; M Bassetti; T Calandra; J Garbino; B J Kullberg; O Lortholary; W Meersseman; M Akova; M C Arendrup; S Arikan-Akdagli; J Bille; E Castagnola; M Cuenca-Estrella; J P Donnelly; A H Groll; R Herbrecht; W W Hope; H E Jensen; C Lass-Flörl; G Petrikkos; M D Richardson; E Roilides; P E Verweij; C Viscoli; A J Ullmann
Journal:  Clin Microbiol Infect       Date:  2012-12       Impact factor: 8.067

4.  Emergence of echinocandin-resistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy?

Authors:  A Fekkar; E Dannaoui; I Meyer; S Imbert; J Y Brossas; M Uzunov; G Mellon; S Nguyen; E Guiller; E Caumes; V Leblond; D Mazier; M H Fievet; A Datry
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-04-09       Impact factor: 3.267

5.  Echinocandin susceptibility testing of Candida isolates collected during a 1-year period in Sweden.

Authors:  Marlene Axner-Elings; Silvia Botero-Kleiven; Rasmus Hare Jensen; Maiken Cavling Arendrup
Journal:  J Clin Microbiol       Date:  2011-05-04       Impact factor: 5.948

6.  Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories.

Authors:  E Dannaoui; A Paugam; M Develoux; C Chochillon; J Matheron; A Datry; C Bouges-Michel; C Bonnal; F Dromer; S Bretagne
Journal:  Clin Microbiol Infect       Date:  2009-09-23       Impact factor: 8.067

7.  Acquired resistance to echinocandins in Candida albicans: case report and review.

Authors:  Marie-Thérèse Baixench; Naji Aoun; Marie Desnos-Ollivier; Dea Garcia-Hermoso; Stéphane Bretagne; Sandrine Ramires; Christophe Piketty; Eric Dannaoui
Journal:  J Antimicrob Chemother       Date:  2007-04-27       Impact factor: 5.790

8.  Comparison between the EUCAST procedure and the Etest for determination of the susceptibility of Candida species isolates to micafungin.

Authors:  Laura Judith Marcos-Zambrano; Pilar Escribano; Cristina Rueda; Óscar Zaragoza; Emilio Bouza; Jesús Guinea
Journal:  Antimicrob Agents Chemother       Date:  2013-08-26       Impact factor: 5.191

9.  EUCAST technical note on Candida and micafungin, anidulafungin and fluconazole.

Authors:  Maiken Cavling Arendrup; Manuel Cuenca-Estrella; Cornelia Lass-Flörl; William W Hope
Journal:  Mycoses       Date:  2014-01-13       Impact factor: 4.377

10.  Candida spp. with acquired echinocandin resistance, France, 2004-2010.

Authors:  Eric Dannaoui; Marie Desnos-Ollivier; Dea Garcia-Hermoso; Fredéric Grenouillet; Sophie Cassaing; Marie-Thérèse Baixench; Stéphane Bretagne; Françoise Dromer; Olivier Lortholary
Journal:  Emerg Infect Dis       Date:  2012-01       Impact factor: 6.883
View more
  7 in total

1.  Intra- and Interlaboratory Agreement in Assessing the In Vitro Activity of Micafungin against Common and Rare Candida Species with the EUCAST, CLSI, and Etest Methods.

Authors:  J Meletiadis; E Geertsen; I Curfs-Breuker; J F Meis; J W Mouton
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

2.  Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method.

Authors:  A Espinel-Ingroff; M Arendrup; E Cantón; S Cordoba; E Dannaoui; J García-Rodríguez; G M Gonzalez; N P Govender; E Martin-Mazuelos; M Lackner; C Lass-Flörl; M J Linares Sicilia; M A Rodriguez-Iglesias; T Pelaez; R K Shields; G Garcia-Effron; J Guinea; M Sanguinetti; J Turnidge
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

3.  Fluconazole and Echinocandin Resistance of Candida glabrata Correlates Better with Antifungal Drug Exposure Rather than with MSH2 Mutator Genotype in a French Cohort of Patients Harboring Low Rates of Resistance.

Authors:  Sarah Dellière; Kelley Healey; Maud Gits-Muselli; Bastien Carrara; Alessandro Barbaro; Nicolas Guigue; Christophe Lecefel; Sophie Touratier; Marie Desnos-Ollivier; David S Perlin; Stéphane Bretagne; Alexandre Alanio
Journal:  Front Microbiol       Date:  2016-12-23       Impact factor: 5.640

4.  Antifungal drug susceptibility, molecular basis of resistance to echinocandins and molecular epidemiology of fluconazole resistance among clinical Candida glabrata isolates in Kuwait.

Authors:  Zahraa F Al-Baqsami; Suhail Ahmad; Ziauddin Khan
Journal:  Sci Rep       Date:  2020-04-10       Impact factor: 4.379

Review 5.  Antifungal Susceptibly Testing by Concentration Gradient Strip Etest Method for Fungal Isolates: A Review.

Authors:  Eric Dannaoui; Ana Espinel-Ingroff
Journal:  J Fungi (Basel)       Date:  2019-11-22

Review 6.  Antifungal Resistance among Less Prevalent Candida Non-albicans and Other Yeasts versus Established and under Development Agents: A Literature Review.

Authors:  Ana Espinel-Ingroff; Emilia Cantón; Javier Pemán
Journal:  J Fungi (Basel)       Date:  2021-01-04

Review 7.  Susceptibility Testing of Fungi to Antifungal Drugs.

Authors:  Maurizio Sanguinetti; Brunella Posteraro
Journal:  J Fungi (Basel)       Date:  2018-09-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.